SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group ($DJT) is trending as the community fiercely debates the escalating Middle East conflict involving Trump's actions against Iran, with discussions centered on its geopolitical ramifications, the impact on American resources, and surging global oil prices.

Chevron Corp. engages in the provision of oil and gas energy solutions. It provides crude oil and natural gas, manufactures transportation fuels, lubricants, petrochemicals, and additives, and develops technologies that enhance business and the industry. It operates through the Upstream and Downstream segments. The Upstream segment consists of the exploration, development, and production of crude oil and natural gas, the liquefaction, transportation, and regasification associated with liquefied natural gas, the transporting of crude oil by major international oil export pipelines, the processing, transporting, storage, and marketing of natural gas, and a gas-to-liquids plant. The Downstream segment consists of the refining of crude oil into petroleum products, the marketing of crude oil and refined products, the transporting of crude oil and refined products by pipeline, marine vessel, motor equipment, and rail car, and the manufacturing and marketing of commodity petrochemicals and plastics for industrial uses and fuel & lubricant additives. The company was founded on September 10, 1879 and is headquartered in Houston, TX.

Chevron Corp.

Chevron is trending as escalating Middle East tensions drive crude prices to multi-year highs amid supply concerns and attacks on oil infrastructure, while the company also gains new production opportunities in Venezuela. The community is actively discussing the perceived disconnect between soaring oil prices and Chevron's stock performance, with many remaining bullish on its strategic positioning.

Petróleo Brasileiro SA engages in oil and gas exploration, production, and distribution activities. It operates through the following segments: Exploration and Production; Refining, Transportation, and Marketing; and Gas and Low Carbon Energies. The Exploration and Production segment covers the activities of exploration, development, and production of crude oil, natural gas liquid, and natural gas, for the primary purpose of supplying its domestic refineries. The Refining, Transportation, and Marketing segment refers to refining, logistics, transport, and trading of crude oil and oil products activities as well as exports of ethanol. The Gas and Low Carbon Energies represents the activities of logistic and trading of natural gas and electricity, transportation and trading of liquefied natural gas, generation and electricity by means of thermoelectric power plants, as well as holding interests in transporters and distributors of natural gas. The company was founded on October 3, 1953 and is headquartered in Rio de Janeiro, Brazil.

Petroleo Brasileiro S.A. Petrobras - ADR

Petroleo Brasileiro

Petroleo Brasileiro is trending as escalating geopolitical tensions in the Middle East drive crude oil prices higher, leading the community to anticipate a significant breakout for the stock. Investors are actively discussing its perceived undervaluation and strong production amidst ongoing conversations about its dividend policy and broader market dynamics.

Intellia Therapeutics, Inc. is a clinical stage genome editing company, which engages in the development of curative therapeutics using the CRISPR/Cas9 system. Its CRISPR/Cas9 system transforms medicine by both producing therapeutics that permanently edit and/or correct disease-associated genes in the human body with a single treatment course, and creates engineered cells that can treat oncological and immunological diseases. The company was founded by Andrew May, Luciano Marraffini, Rodolphe Barrangou, Nessan Bermingham, Rachel Haurwitz, Erik Sontheimer, Jennifer Doudna, and Derrick Rossi in May 2014 and is headquartered in Cambridge, MA.

Intellia Therapeutics Inc

Intellia Therapeutics is actively discussed following the FDA's decision to lift a clinical hold on its MAGNITUDE-2 trial, igniting short squeeze speculation due to high short interest. However, a hold persists on the larger ATTR-CM trial, and recent news of an expanded share offering has fueled community concerns regarding dilution.

iShares Trust - iShares Russell 2000 ETF

iShares Russell 2000 ETF

IWM is trending due to heightened geopolitical tensions in the Middle East and rising oil prices, alongside a weaker jobs report, sparking a divided community debate between those anticipating further small-cap weakness and others buying the dip, noting the sector's long-term undervaluation.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

United States Oil Fund (USO) is trending due to escalating Middle East tensions, with reported strikes on Iranian oil infrastructure and disruptions in the Strait of Hormuz driving community speculation about sustained price surges. Many debate whether this represents a true supply shock or a temporary spike that will reverse due to ample global supply and potential market intervention.

Vale SA engages in the production and exportation of iron ore, pellets, manganese, and iron alloys. It operates through the following segments: Iron Solutions, Energy Transition Materials and Others. The Iron Solutions segment includes the production and extraction of iron ore, iron ore pellets, manganese, other ferrous products, and logistic services. The Energy Transition Materials segment involves the production and extraction of nickel and its by-products. Others includes the revenues and cost of other products, services, research and development, investments in joint ventures and associates of other business. The company was founded on June 1, 1942 and is headquartered in Rio de Janeiro, Brazil.

Vale S.A. - ADR

Vale S.A.

Vale S.A. is trending with strong community interest fueled by the ongoing commodity supercycle narrative, particularly robust demand for copper and resilient iron ore markets, leading many to see the stock as undervalued despite recent mixed operational reports.

Li Auto, Inc. engages in the design, development, manufacture, and sale of premium smart electric vehicles. Its products include Li MEGA, a high-tech flagship family MPV, Li L9, a six-seat flagship family SUV, and Li L8, a six-seat premium family SUV, and Li L7, a five-seat flagship family SUV. The firm also offers in-house development efforts on its proprietary range extension system, next-generation electric vehicle technology, and smart vehicle solutions. The company was founded by Xiang Li in April 2015 and is headquartered in Beijing, China.

Li Auto Inc - ADR

Li Auto is trending as its recent weak February delivery numbers and an analyst downgrade fuel concerns over slowing demand and intense competition within the Chinese EV market. The community is actively debating the company's challenging pivot to pure electric vehicles and its future growth trajectory compared to rivals.

Abivax SA engages in the sale, research, distribution, and development of biopharmaceutical products. It offers commercial and development products of anti-viral compounds and human vaccines. The commercialized products include vaccines for typhoid fever, meningococcus, and leptospirosis. The products under development include vaccines for chronic hepatitis B, ebola, and dengue virus. The company was founded by Philippe Pouletty on December 4, 2003 and is headquartered in Paris, France.

Abivax - ADR

Abivax is currently trending due to heightened acquisition speculation, with reports suggesting significant offers from major pharmaceutical companies like AstraZeneca and previous interest from Eli Lilly, following strong Phase 3 data for its obefazimod drug in ulcerative colitis. The community is actively discussing the potential of this unique inflammatory bowel disease treatment and the valuation of a possible takeover within a consolidating biotech market.

PayPal Holdings, Inc. engages in the development of technology platforms that enable digital payments and simplifies commerce experiences on behalf of merchants and consumers worldwide. Its solutions include PayPal, PayPal Credit, Braintree, Venmo, Xoom, and Paydiant products. The firm also enables consumers to exchange funds with merchants using funding sources, which include bank account, PayPal account balance, PayPal Credit account, credit, and debit card or other stored value products. It operates through United States and Other Countries geographical segments. The company was founded in December 1998 and is headquartered in San Jose, CA.

PayPal Holdings Inc

PayPal is seeing high community discussion amid conflicting reports regarding a potential acquisition, as investors widely debate its perceived undervaluation and anticipate aggressive strategic changes from the new CEO, particularly after rival Block's recent stock surge following significant workforce reductions.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

https://nfne.ws/248388 $MUSLF #Beverages #Food #Sports #CSEStocks #OTC #OTCMarkets #OTCStocks #SmallCaps #Investing

Research to explore Promino's patented amino acid blend in addressing treatment-related muscle wasting in two of the most prevalent cancers...

Newsfile

Promino Nutritional Sciences Inc. Launches Second Preclinical Study Targeting Reduction of Muscle Loss in Breast and Prostate Cancer Patients Undergoing Chemotherapy